Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

PHASE2CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

April 18, 2018

Primary Completion Date

November 15, 2019

Study Completion Date

November 15, 2019

Conditions
Vasomotor Symptoms (VMS)
Interventions
DRUG

MT-8554

MT-8554 Oral

Trial Locations (53)

19114

Research Site, Philadelphia

21208

Research Site, Baltimore

23502

Research Site, Norfolk

27103

Research Site, Winston-Salem

28557

Research Site, Morehead City

30328

Research Site, Sandy Springs

32081

Research Site, Ponte Vedra

32256

Research Site, Jacksonville

32801

Research Site, Orlando

32806

Research Site, Orlando

33012

Research Site, Hialeah

33016

Research Site, Hialeah

33176

Research Site, New London

Research Site, Miami

33185

Research Site, Miami

33409

Research Site, West Palm Beach

33414

Research Site, Wellington

33458

Research Site, Jupiter

33759

Research Site, Clearwater

33900

Research Site, Fort Myers

34231

Research Site, Sarasota

34429

Research Site, Crystal River

34952

Research Site, Port Saint Lucie

35209

Research Site, Birmingham

36303

Research Site, Dothan

37620

Research Site, Bristol

38119

Research Site, Memphis

38305

Research Site, Jackson

43213

Research Site, Columbus

43231

Research Site, Columbus

44101

Research Site, Cleveland

45322

Research Site, Englewood

48504

Research Site, Saginaw

49009

Research Site, Kalamazoo

59801

Research Site, Missoula

64114

Research Site, Kansas City

67226

Research Site, Wichita

67501

Research Site, Hutchinson

70001

Research Site, Metairie

70072

Research Site, Marrero

76104

Research Site, Fort Worth

78154

Research Site, Schertz

80209

Research Site, Denver

83404

Research Site, Idaho Falls

84020

Research Site, Draper

84107

Research Site, Salt Lake City

85032

Research Site, Phoenix

89128

Research Site, Las Vegas

90650

Research Site, Norwalk

92111

Research Site, San Diego

94203

Research Site, Sacramento

98101

Research Site, Seattle

08648

Research Site, Lawrenceville

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY